Phase I and pharmacological studies of pentamethylmelamine administered by 24-hour intravenous infusion.

Casper, E S; Gralla, R J; Lynch, G R; Jones, B R; Woodcock, T M; Gordon, C; Kelsen, D P; Young, C W

Casper, E S; Gralla, R J; Lynch, G R; Jones, B R; Woodcock, T M; Gordon, C; Kelsen, D P; Young, C W.

Cancer Res ; 41(4): 1402-6, 1981 Apr.

Article in En | MEDLINE | ID: mdl-6783296

Subject(s)

Altretamine/administration & dosage; Antineoplastic Agents/administration & dosage; Kidney Neoplasms/drug therapy; Lung Neoplasms/drug therapy; Triazines/administration & dosage; Adult; Aged; Altretamine/adverse effects; Altretamine/analogs & derivatives; Altretamine/urine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Nausea/chemically induced; Prognosis; Vomiting/chemically induced

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Triazines / Altretamine / Kidney Neoplasms / Lung Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Res Year: 1981 Type: Article

Search on Google

XML

PubMed Links